Cargando…
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal characteristics of antibodies targeting various antigens after asymptomatic to mild COVID-19 are yet to be established. This longitudinal cohort study including 1965 healthcare workers, of which 381 participants...
Autores principales: | Havervall, Sebastian, Jernbom Falk, August, Klingström, Jonas, Ng, Henry, Greilert-Norin, Nina, Gabrielsson, Lena, Salomonsson, Ann-Christin, Isaksson, Eva, Rudberg, Ann-Sofie, Hellström, Cecilia, Andersson, Eni, Olofsson, Jennie, Skoglund, Lovisa, Yousef, Jamil, Pin, Elisa, Christ, Wanda, Olausson, Mikaela, Hedhammar, My, Tegel, Hanna, Mangsbo, Sara, Phillipson, Mia, Månberg, Anna, Hober, Sophia, Nilsson, Peter, Thålin, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754314/ https://www.ncbi.nlm.nih.gov/pubmed/35020778 http://dx.doi.org/10.1371/journal.pone.0262169 |
Ejemplares similares
-
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
por: Havervall, Sebastian, et al.
Publicado: (2021) -
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
por: Rudberg, Ann-Sofie, et al.
Publicado: (2020) -
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
por: Havervall, Sebastian, et al.
Publicado: (2021) -
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
por: Havervall, Sebastian, et al.
Publicado: (2022) -
A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
por: Mravinacova, Sara, et al.
Publicado: (2022)